COMMUNIQUÉS West-GlobeNewswire

Merus annonce la publication des résumés qui seront présentés à la réunion annuelle 2024 de l’ASCO®
25/05/2024
Présentation orale rapide du MCLA-145 en monothérapie et en association avec le pembrolizumab : 2 juin 2024, 11 h 30-13 h, heure centrale Présentation sur affiche du MCLA-129 dans le cancer bronchique non à petites [...]
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
25/05/2024
MELVILLE, N.Y., May 24, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today [...]
Halo Dental Technologies Showcase Their Digital Mirror at Montreal-based JDIQ Annual Conference
25/05/2024
At the largest bilingual dental convention in North America, Halo will showcase the first-of-its-kind digital dental mirror at its home-city event, for leading dentists and hygienists in Canada. MONTREAL, May 24, 2024 ( [...]
Halo Technologies Dentaires présente son Miroir Numérique à la conférence annuelle JDIQ à Montréal
25/05/2024
Lors de la plus grande convention dentaire bilingue en Amérique du Nord, Halo présentera son miroir dentaire numérique unique en son genre lors de cet événement dans sa ville natale, destiné aux dentistes et hygiénistes [...]
Celularity Inc. Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
24/05/2024
FLORHAM PARK, N.J., May 24, 2024 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a regenerative medicine company developing placental-derived allogeneic cell therapies and advanced biomaterial [...]
Rakovina Therapeutics Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
24/05/2024
All monetary figures listed in Canadian Dollars. VANCOUVER, British Columbia, May 24, 2024 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“ Rakovina ” or the “ Company ”) (TSX-V: RKV) announces that in accordance with [...]
Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting
24/05/2024
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced the presentation of three abstracts that highlights data from [...]
R1 RCM to Present at the 2024 Jefferies Global Healthcare Conference
24/05/2024
MURRAY, Utah, May 24, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today [...]
OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q
24/05/2024
ROCKVILLE, Md., May 24, 2024 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”) announced today that it received a notice from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company was [...]
Iovance Biotherapeutics to Present at Upcoming Conferences and Events
24/05/2024
SAN CARLOS, Calif., May 24, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte [...]
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
24/05/2024
SAN DIEGO, May 24, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or “the Company”), a clinical stage biotechnology company engaged in the discovery and development of first-in-class medicines from [...]
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
24/05/2024
WALTHAM, Mass., May 24, 2024 (GLOBE NEWSWIRE) -- Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB (Sobi ® ), today announced that the US Food and Drug Administration (FDA) has granted Fast [...]
Appointment of new CFO
24/05/2024
ANNOUNCEMENT NO. 269 Appointment of new CFO The board of ChemoMetec has appointed Kim Nicolajsen as new CFO with effect from 1 July 2024. Kim Nicolajsen comes from a similar position as CFO in the family-owned company [...]
Scilex Holding Company Announces it has been Added to the MSCI Global Microcap Index
24/05/2024
Has the potential to Enhance the visibility of Scilex’s Non-Opioid Pain Management Therapeutics In Global Financial Markets PALO ALTO, Calif., May 24, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “ [...]
Guerbet : Hugues Lecat nommé Président du Conseil d’administration de Guerbet.
24/05/2024
Hugues Lecat nommé Président du Conseil d’administration de Guerbet Villepinte, le 24 mai 2024 : Guerbet (FR0000032526 GBT), spécialiste mondial des produits de contraste et solutions pour l’imagerie médicale, annonce [...]
Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.
24/05/2024
Hugues Lecat appointed Chairman of the Board of Directors of Guerbet Villepinte, 24 May 2024 : Guerbet (FR0000032526 GBT), a global specialist in contrast products and solutions for medical imaging, is announcing the [...]
BioSenic provides First Quarter 2024 Business Update
24/05/2024
PRESS RELEASE – REGULATED INFORMATION Mont-Saint-Guibert, Belgium, May 24, 2024, 17.00am CET – BioSenic (Euronext Brussels and Paris: BIOS) , the clinical stage company specializing in serious autoimmune and [...]
BioSenic fait le point sur ses activités du premier trimestre 2024
24/05/2024
COMMUNIQUE DE PRESSE – INFORMATION REGLEMENTEE Mont-Saint-Guibert, Belgique, le 24 mai 2024 à 17h00 CEST – BIOSENIC (Euronext Bruxelles et Paris : BIOS), la société en phase clinique spécialisée dans les maladies auto- [...]
Purespring Therapeutics presents preclinical data at the 61st ERA Congress
24/05/2024
Purespring Therapeutics presents preclinical data at the 61 st ERA Congress Data establishes the potential of AAV gene therapy to deliver transgenes to the podocyte to replace defective genes or to modulate protein [...]

Pages